Fluorinated hydroxyapatite conditions a favorable osteo-immune microenvironment via triggering metabolic shift from glycolysis to oxidative phosphorylation

• Published in: Journal of translational medicine Vol. 22; no. 1; p. 437
• Main Authors: Chen, Kaidi, Ha, Seongmin, Xu, Leyao, Liu, Chengwu, Liu, Yuanxiang, Wu, Xiayi, Li, Zhipeng, Wu, Shiyu, Yang, Bo, Chen, Zhuofan
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 08.05.2024; BioMed Central; BMC
• Subjects: Analysis; Animals; Bone and Bones - drug effects; Bone and Bones - metabolism; Bone diseases; Bone regeneration; Care and treatment; Cell Proliferation - drug effects; Cellular Microenvironment - drug effects; Diagnosis; Durapatite - chemistry; Fluoride; Glucose metabolism; Glycolysis - drug effects; Health aspects; Macrophages; Macrophages - drug effects; Macrophages - metabolism; Male; Metabolic shift; Mice; Osteo-immunomodulation; Osteogenesis - drug effects; Oxidative Phosphorylation - drug effects; Rats; Rats, Sprague-Dawley; RAW 264.7 Cells; Skull - drug effects; Skull - pathology; Swine; China; Metabolic shift; Osteo-immunomodulation; Fluoride; Macrophages; Bone regeneration
• ISSN: 1479-5876; 1479-5876
• DOI: 10.1186/s12967-024-05261-0

Biological-derived hydroxyapatite is widely used as a bone substitute for addressing bone defects, but its limited osteoconductive properties necessitate further improvement. The osteo-immunomodulatory properties hold crucial promise in maintaining bone homeostasis, and precise modulation of macrophage polarization is essential in this process. Metabolism serves as a guiding force for immunity, and fluoride modification represents a promising strategy for modulating the osteoimmunological environment by regulating immunometabolism. In this context, we synthesized fluorinated porcine hydroxyapatite (FPHA), and has demonstrated its enhanced biological properties and osteogenic capacity. However, it remains unknown whether and how FPHA affects the immune microenvironment of the bone defects. FPHA was synthesized and its composition and structural properties were confirmed. Macrophages were cultured with FPHA extract to investigate the effects of FPHA on their polarization and the related osteo-immune microenvironment. Furthermore, total RNA of these macrophages was extracted, and RNA-seq analysis was performed to explore the underlying mechanisms associated with the observed changes in macrophages. The metabolic states were evaluated with a Seahorse analyzer. Additionally, immunohistochemical staining was performed to evaluate the macrophages response after implantation of the novel bone substitutes in critical size calvarial defects in SD rats. The incorporation of fluoride ions in FPHA was validated. FPHA promoted macrophage proliferation and enhanced the expression of M2 markers while suppressing the expression of M1 markers. Additionally, FPHA inhibited the expression of inflammatory factors and upregulated the expression of osteogenic factors, thereby enhancing the osteogenic differentiation capacity of the rBMSCs. RNA-seq analysis suggested that the polarization-regulating function of FPHA may be related to changes in cellular metabolism. Further experiments confirmed that FPHA enhanced mitochondrial function and promoted the metabolic shift of macrophages from glycolysis to oxidative phosphorylation. Moreover, in vivo experiments validated the above results in the calvarial defect model in SD rats. In summary, our study reveals that FPHA induces a metabolic shift in macrophages from glycolysis to oxidative phosphorylation. This shift leads to an increased tendency toward M2 polarization in macrophages, consequently creating a favorable osteo-immune microenvironment. These findings provide valuable insights into the impact of incorporating an appropriate concentration of fluoride on immunometabolism and macrophage mitochondrial function, which have important implications for the development of fluoride-modified immunometabolism-based bone regenerative biomaterials and the clinical application of FPHA or other fluoride-containing materials.